Track 3: Cell and Gene Therapy Products, ATMPs, Projects, Commercial Manufacturing

Speaker(s):

• Alessandro Linciano, Project Director, Stein Cell & Gene Therapy, Novartis Technical Operation
• Angel Alvarez-Mangual, Senior Manager, Process Sciences, Cellectis
• Leslie M. Edwards, MSE, Vice President, Technology & Business Development, Skan US
• Jennifer Cheung, Vice President Quality Assurance and Regulatory Affairs, WuXi Advanced Therapies
• Amy Hardwick, Technical Regulatory Program Associate Director, INeST, Genentech
• J. Andrew Case, Head of Clinical Supply Chain - Individualized Therapies, Genentech